OP5 Economic and Organizational Impact of Subcutaneous Ocrelizumab in French Daily Hospitals
Abstract
Authors
Léopoldine du Manoir de Juaye Katya Galactionova Bertrand Bourre Marie-Hélène Colpaert Andrea Lazzarotto Yasmine Nivoix